Doxepin
Overview
Doxepin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1628227).
API suppliers (5)
Suppliers of Doxepin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 5 suppliers.
1 of 5 holds a GMP certificate on record in the EU or UK registers
- TAPI NL BVNetherlands1 active DMF
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- RAKS PHARMA PVT LTDIndia1 active DMF
- BOEHRINGER MANNHEIM GMBH
- SUMIKA FINE CHEMICALS CO LTD
Patent & exclusivity (US)
Per the FDA Orange Book (106 approved US products), the latest listed US patent on Doxepin expires 7 Sept 2030. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
- Canonical SMILES
- CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31
- InChIKey
- ODQWQRRAPPTVAG-UHFFFAOYSA-N
Do you supply Doxepin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.